KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,800 | -83.4% | 120,000 | -77.8% | 0.01% | -82.9% |
| Q2 2023 | $966,138 | -45.2% | 539,742 | +96.8% | 0.04% | -63.9% |
| Q4 2021 | $1,763,000 | +424.7% | 274,243 | +375.1% | 0.10% | +470.6% |
| Q3 2021 | $336,000 | -96.8% | 57,726 | -94.3% | 0.02% | -95.8% |
| Q2 2021 | $10,371,000 | -25.9% | 1,004,962 | -24.5% | 0.40% | -10.7% |
| Q1 2021 | $14,003,000 | +245.6% | 1,331,104 | +408.6% | 0.45% | +118.4% |
| Q4 2020 | $4,052,000 | +16.5% | 261,729 | +9.9% | 0.21% | -12.7% |
| Q3 2020 | $3,477,000 | +81.3% | 238,104 | +135.2% | 0.24% | +98.3% |
| Q2 2020 | $1,918,000 | +253.2% | 101,249 | +257.9% | 0.12% | +83.1% |
| Q1 2020 | $543,000 | -15.6% | 28,290 | -15.6% | 0.06% | +41.3% |
| Q4 2019 | $643,000 | -78.4% | 33,535 | -89.2% | 0.05% | -79.4% |
| Q3 2019 | $2,978,000 | – | 309,579 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |